AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)
0.27 USD
-0.051 15.809%Sponsored Reports
Loading...
| Previous Close (in USD) | 0.3207 |
|---|---|
| Change | -0.051 15.809% |
| 52 W H/L (in USD) | 2.800/0.600 |
| EBITDA (in USD) | -9.803M |
| PE Ratio | -- |
| Volume | 22303 |
| Diluted Eps TTM | -3.28 |
| Total Assets (in USD) | 18.822M |
|---|---|
| Total Liabilities (in USD) | 3.076M |
| Revenue TTM (in USD) | -- |
| Cash (in USD) | 16.351M |
| Market Cap (in USD) | 2.303 M |
| Revenue Per Share TTM | -- |
| Gross Profit TTM (in USD) | -- |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
InVivo Therapeutics Holdings Corp
InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
One Kendall Square, Cambridge, MA, United States, 02139
617 863 5500
Employees: 6
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Dr. Richard M. Toselli | Pres, CEO, Chief Medical Officer & Director | 1958 |
| 2. | Mr. Richard C. Christopher | CFO & Treasurer | 1970 |
| 3. | Dr. Robert S. Langer Jr., Ph.D., Sc.D., SCD | Co-Founder & Member of Scientific Advisory Board | 1949 |
| 4. | Dr. Joseph Philip Vacanti | Co-Founder | 1949 |
| 5. | Mr. Jerome Gangitano | Sr. VP of Operations | NA |
| 6. | Ms. Heather M. Hamel J.D. | Chief Legal Officer & Gen. Counsel | NA |
| 7. | Dr. Louis Vaickus FACP, M.D. | Consultant | 1953 |
Peers
Sector: Healthcare
Industry: Biotechnology
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
NVO
Novo Nordisk A/S |
+2.240 3.480% | 65.37 | 41.580 | 31.153 | 2.134 | 32.989 | 2.113 | 4.700 |
|
NONOF
Novo Nordisk A/S |
+3.260 5.151% | 66.55 | 41.060 | 31.250 | 2.078 | 33.111 | 2.113 | 4.700 |
|
VRTX
Vertex Pharmaceuticals Inc |
+0.070 0.016% | 437.49 | 29.670 | 24.331 | 10.385 | 5.832 | 9.334 | 20.004 |
|
REGN
Regeneron Pharmaceuticals Inc |
-0.110 0.019% | 588.48 | 29.070 | 20.121 | 7.570 | 3.823 | 6.950 | 19.423 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | -10.49M | -9.895M | -9.074M | -11.83M | -23.423M |
| Minority Interest | - | - | - | - | - |
| Net Income | -10.179M | -9.892M | -9.055M | -12.242M | -46.244M |
| Selling General Administrative | 5.424M | 5.519M | 5.158M | 5.895M | 7.836M |
| Gross Profit | - | - | - | - | 0M |
| Reconciled Depreciation | 0.445M | 0.372M | 0.329M | 0.322M | 0.091M |
| Ebit | -10.65M | -9.9M | -9.097M | -11.497M | -12.767M |
| Ebitda | -10.205M | -9.528M | -8.768M | -10.509M | -0.511M |
| Depreciation And Amortization | 0.445M | 0.372M | 0.329M | 0.988M | 12.256M |
| Operating Income | -10.65M | -9.9M | -9.097M | -11.497M | -12.767M |
| Other Operating Expenses | 10.65M | 9.9M | 9.097M | 11.497M | 12.767M |
| Interest Expense | 0.151M | 0.003M | 0.019M | 0.254M | 0.206M |
| Tax Provision | - | - | - | - | - |
| Interest Income | - | 0.003M | - | 0.254M | 11.959M |
| Net Interest Income | 0.151M | 0.003M | 0.019M | 0.254M | 0.206M |
| Income Tax Expense | -0.311M | -0.003M | -0.019M | 0.412M | 22.821M |
| Total Revenue | 0M | 0M | 0M | 0M | 0M |
| Total Operating Expenses | 10.65M | 9.9M | 9.097M | 11.497M | 12.767M |
| Cost Of Revenue | - | - | - | - | 0M |
| Total Other Income Expense Net | 0.16M | 0.005M | 0.023M | -0.333M | -10.656M |
| Net Income From Continuing Ops | -10.49M | -9.895M | -9.074M | -11.83M | -23.423M |
| Net Income Applicable To Common Shares | -10.49M | -9.895M | -9.074M | -11.83M | -23.423M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Total Assets | 18.822M | 21.77M | 21.91M | 9.325M | 18.377M |
| Intangible Assets | - | - | 0.009M | 0.026M | 0.044M |
| Other Current Assets | 1.153M | 0.111M | 0.163M | 0.181M | 0.465M |
| Total Liab | 3.076M | 3.655M | 2.724M | 3.742M | 2.266M |
| Total Stockholder Equity | 15.746M | 18.115M | 19.186M | 5.583M | 16.111M |
| Other Current Liab | 1.455M | 1.646M | 1.164M | 1.427M | 1.29M |
| Common Stock | 0.003M | 0.003M | 0.003M | 0.002M | 0.001M |
| Capital Stock | 0.003M | 0.003M | 0.003M | 0.002M | 0.001M |
| Retained Earnings | -248.619M | -238.129M | -228.234M | -219.16M | -207.33M |
| Good Will | - | - | - | - | - |
| Other Assets | 0.15M | 1.272M | 2.169M | 1.232M | 1.108M |
| Cash | 16.351M | 19.031M | 19.493M | 6.602M | 16.66M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 2.468M | 2.612M | 1.972M | 2.663M | 2.205M |
| Current Deferred Revenue | - | - | - | - | - |
| Net Debt | -15.402M | -17.721M | -18.473M | -5.288M | -16.56M |
| Short Term Debt | 0.396M | 0.361M | 0.327M | 0.294M | 0.1M |
| Short Long Term Debt | - | - | - | - | 0.1M |
| Short Long Term Debt Total | 0.949M | 1.31M | 1.02M | 1.314M | 0.1M |
| Other Stockholder Equity | 264.362M | 256.241M | 247.417M | 224.741M | 223.44M |
| Property Plant Equipment | 1.071M | 1.356M | 0.085M | 0.073M | 0.1M |
| Total Current Assets | 17.601M | 19.142M | 19.656M | 6.783M | 17.125M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | - | - | - | - | - |
| Net Receivables | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Accounts Payable | 0.617M | 0.605M | 0.481M | 0.942M | 0.815M |
| Accumulated Other Comprehensive Income | - | - | - | -0.644M | -0.605M |
| Non Currrent Assets Other | 0.15M | 1.272M | 1.232M | 1.232M | 1.152M |
| Non Current Assets Total | 1.221M | 2.628M | 2.254M | 2.542M | 1.252M |
| Capital Lease Obligations | 0.949M | 1.31M | 1.02M | 1.314M | - |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Investments | -0.16M | -0.077M | -0.041M | -0.012M | -0.065M |
| Total Cashflows From Investing Activities | -0.16M | -0.077M | -0.041M | -0.012M | -0.065M |
| Total Cash From Financing Activities | 7.962M | 8.509M | 22.462M | 0.268M | 15.88M |
| Net Income | -10.49M | -9.895M | -9.074M | -11.83M | -23.423M |
| Change In Cash | -2.68M | -0.422M | 12.887M | -10.058M | 3.503M |
| Begin Period Cash Flow | 19.181M | 19.603M | 6.716M | 16.774M | 13.271M |
| End Period Cash Flow | 16.501M | 19.181M | 19.603M | 6.716M | 16.774M |
| Total Cash From Operating Activities | -10.482M | -8.854M | -9.534M | -10.314M | -12.312M |
| Depreciation | 0.445M | 0.372M | 0.329M | 0.322M | 0.091M |
| Other Cashflows From Investing Activities | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | - | - | - | - | - |
| Sale Purchase Of Stock | - | - | 0.343M | 0.001M | 0.121M |
| Other Cashflows From Financing Activities | -0.16M | 8.509M | 0.343M | 0.001M | 0.121M |
| Capital Expenditures | 0.16M | 0.077M | 0.041M | 0.012M | 0.065M |
| Change In Working Capital | -0.596M | 0.354M | -1.004M | 0.259M | -1.217M |
| Other Non Cash Items | - | 1.508M | -14.568M | 0.667M | 11.619M |
| Free Cash Flow | -10.642M | -8.931M | -9.575M | -10.326M | -12.377M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Vanguard Institutional Extnd Mkt Idx Tr | 1 year ago | 31238 |
| 2. | Fidelity® Extended Market Index | 1 year ago | 14495 |
| 3. | Fidelity® Series Total Market Index | 1 year ago | 2425 |
| 4. | Fidelity Nasdaq Composite Index | 1 year ago | 1757 |
| 5. | NT Ext Equity Mkt Idx Fd - NL | 1 year ago | 1582 |
| 6. | NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 1 year ago | 1268 |
| 7. | Northern Trust Extended Eq Market Idx | 1 year ago | 1195 |
| 8. | NT Ext Equity Mkt Idx Fd - L | 1 year ago | 1195 |
| 9. | NT Ext Eq Mkt Indx Fd DC Lending Tier 5 | 1 year ago | 51 |
| 10. | InterOcean Capital Group EIO | 1 year ago | 50 |
| 11. | Northern Trust Wilshire 5000 | 1 year ago | 46 |
| 12. | NT US Market Cap Idx Fd - L | 1 year ago | 46 |
| 13. | BlackRock Extended Equity Market K | 1 year ago | 3 |
| 14. | BlackRock Extended Mkt Composite | 1 year ago | 3 |
| 15. | State St US Extended Mkt Indx NL Cl C | 1 year ago | 2 |
| 16. | iShares Core S&P Total US Stock Mkt ETF | 1 year ago | 2 |
| 17. | SSgA U.S. Extended Market Index Class I | 1 year ago | 1 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | BlackRock Inc | 1 year ago | 34714 |
| 2. | Vanguard Group Inc | 1 year ago | 28938 |
| 3. | Geode Capital Management, LLC | 1 year ago | 18677 |
| 4. | Renaissance Technologies Corp | 1 year ago | 13921 |
| 5. | Tower Research Capital LLC | 1 year ago | 7593 |
| 6. | Morgan Stanley - Brokerage Accounts | 1 year ago | 270 |
| 7. | UBS Group AG | 1 year ago | 102 |
| 8. | Wells Fargo & Co | 1 year ago | 23 |
| 9. | Advisor Group Holdings, Inc. | 1 year ago | 6 |
| 10. | Hanson Mcclain Inc | 1 year ago | 2 |
| 11. | Indiana Trust & Investment Management Co | 1 year ago | 2 |
| 12. | Milestone Investment Advisors LLC | 1 year ago | 2 |
| 13. | Colonial Asset Management Inc | 1 year ago | 2 |
| 14. | Sugarloaf Wealth Management, LLC | 1 year ago | 1 |
| 15. | TD Waterhouse Canada Inc | 1 year ago | 0 |
| 16. | FMR Inc | 1 year ago | 0 |
| 17. | Feltz Wealth PLAN Inc. | 1 year ago | 0 |
| 18. | Millennium Management LLC | 1 year ago | 0 |
| 19. | TWO SIGMA SECURITIES, LLC | 1 year ago | 0 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...